Sign in

CIK 0001806310 · Non-accelerated filer<br>Smaller reporting company

Taysha Gene Therapies, Inc.

Sign in to watch
Ticker
TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843199512
Phone
(214) 612-0000
Business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
  1. DEF 14A Proxy Proxy Statement
  2. DEF 14A Proxy Proxy Statement
  3. PRE 14A Proxy Proxy Statement (Preliminary)
  4. DEF 14A Proxy Proxy Statement
  5. DEF 14A Proxy Proxy Statement
  6. PRE 14A Proxy Proxy Statement (Preliminary)
  7. DEF 14A Proxy Proxy Statement
  8. PRE 14A Proxy Proxy Statement (Preliminary)
  9. DEF 14A Proxy Proxy Statement
  10. DEF 14A Proxy Proxy Statement

Page 1 of 1 · 10 filings